Adjuvant therapy targeting epigenetic modulators (DNA methyltransferase and HDAC) after surgical removal of the tumor also showed inhibition of MDSC accumulation in the lung premetastatic niche and longer disease-free survival (126). This evidence concerns the gene HDAC9 and neoplasm.